1070 5/500 (Xigduo XR 5 mg / 500 mg)
Generic Name: dapagliflozin/metformin
Pill imprint 1070 5/500 has been identified as Xigduo XR 5 mg / 500 mg.
Xigduo XR is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Xigduo XR 5 mg / 500 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- dapagliflozin/metformin
- Imprint:
- 1070 5/500
- Strength:
- 5 mg / 500 mg
- Color:
- Orange
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- AstraZeneca Pharmaceuticals
More about Xigduo XR (dapagliflozin / metformin)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
